Peng-chen Chen, Xaiolong Liu and Yao Lin Pages 1 - 8 ( 8 )
The development process for cancer drugs is risky, lengthy and costly. Exploration of the anticancer potential of listed non-cancer drugs has become a popular research field in the pharmaceutical industry. The efficacy of various drugs are tested in multiple cancer types and the mechanisms underlying their effect were investigated. In this review, we have summarized the drug relocation instances for different cancer types in recent years and discussed the future direction of drug repurposing.
Drug repurposing; Cancer; Signaling pathway; cellular experiments
Fujian Normal University, Fuzhou, Fujian, China